Why Is Ensysce Biosciences Stock trading Higher Today? - Ensysce Biosciences (NASDAQ:ENSC)

Ensysce Biosciences breakthrough in opioid innovation! FDA grants PF614-MPAR BTD for enhanced pain relief with overdose protection. Learn more about this cutting-edge drug.

Related Keywords

,Lynn Kirkpatrick ,Ensysce Biosciences ,Ensysce Biosciences Inc ,Biosciences Inc ,Therapy Designation ,Chief Executive Officer ,Breakthrough Therapy Designation ,Trypsin Activated Abuse Protection ,Multi Pill Abuse Resistance ,